In my opinion its good that they are going down this path. Diversifying their value proposition sits well with me. Sure their core function will be the medicinal side of things but you wouldn't want to have a business that has its eggs all in one basket.
This can bring some early revenues and give the company some crediability in the market place.
Europe will be hitting spring soon so would expect to see some results in the coming months.
Just my thoughts
CPH Price at posting:
63.0¢ Sentiment: Buy Disclosure: Held